Hydroxychloroquine (may or) may not turn out to save the human race, regardless of what the orange american thing may say
As said before, studies are tiny, few in number, flawed (the Marseille one has been criticised heavily on social media and in more formal print https://www.isac.world/news-and-publications/official-isac-statement ) and contradictory (one recently from Paris in more poorly patients showed “no benefit” – again small study though)
The possibility of combining hydroxychlorquine and azithromycin as some have proposed carries risks and there MAY have been at least one death attributable to the treatment already (isolated case report but the toxic effects are pretty predictable)
There are proper, big trials taking place that hopefully will answer some of this but a drug that hopes to prevent serious illness in a handful of mildly symptomatic patients is going to need a BIG trial because a lot of those folk will improve spontaneously anyway and we don’t know what predicts the course of disease in all cases.
Whether treatments work in pts who are already significantly more ill is probably going to look easier statistically but standardising or controlling for all other aspects of care is going to be tough
Sorry – have a good week, all. Here’s hoping to see some good, persistent evidence of tailing off in London’s death rates (admission rates supposedly calming down a bit).